Global Self-Monitoring Blood Glucose Device Market
Self-Monitoring Blood Glucose Devices Market Predicted to Reach US$ 21.05 Billion by 2032, Reflecting a CAGR of 6.76%
August 21, 2024 11:28 ET | Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Global Self-Monitoring Blood Glucose Device Market Report by Product, Application, End-User, Regions and Company Analysis 2024-2032" report has been...
Insulin Pump Market
Insulin Pump Market Research Report 2024-2032 with Competitive Analysis of Medtronic, Insulet, Tandem Diabetes Care, Roche, Insulet, Ypsomed, and Microtech Medical
August 19, 2024 10:40 ET | Research and Markets
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pump Market Report by Types, Diseases, Accessories, End-user Countries and Company Analysis 2024-2032" report has been added to ...
Global Insulin Pen Market
Global Insulin Pen Market Poised for Expansion, Projected to Reach US$ 10.71 Billion by 2032, Fueled by Technological Advancements and User-Friendly Designs and International Prevalence of Diabetes
July 24, 2024 11:16 ET | Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market Report by Product, Disease types, Distribution Channels Regions and Company Analysis 2024-2032" report has been added to ...
biodexa-logo-square (1).png
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
July 16, 2024 08:30 ET | Biodexa Pharmaceuticals PLC
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage...
logo 600X600.png
Type 1 Diabetes Market Size to Worth USD 24.36 Bn By 2031
May 16, 2024 05:30 ET | CMI
Burlingame, May 16, 2024 (GLOBE NEWSWIRE) -- The global type 1 diabetes market is estimated to be valued at USD 15.95 Bn in 2024 and is expected to reach USD 24.36 Bn by 2031, according to Coherent...
Global Smart Insulin Pens Market
Global Smart Insulin Pens Market Report 2024, Featuring Profiles of Companion Medical, Emperra, Eli Lilly, Bigfoot Biomedical, Diamesco, Pendiq, Medtronic, Diabnext, Diabecare and Capillary Biomedical
March 25, 2024 12:13 ET | Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering.The global smart insulin pens market accounted for USD...
22157.jpg
Global Insulin Pen Market Report 2024: Data from 2020-2022, Estimates for 2023 and Compound Annual Growth Rates Projections through 2028
February 22, 2024 11:17 ET | Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market was valued at $9.9 billion in...
Blood Glucose Test Strips Market Blood Glucose Test Strips Market Growth Rate By Region 2023 2028
Global Blood Glucose Test Strips Market Trends and Forecast 2023-2028: A Projected $14.29 Billion Industry by 2028
February 09, 2024 05:56 ET | Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Blood Glucose Test Strips Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ...
Let's Make Time for Diabetes Awareness Month
“We’re never off the clock”: Diabetes Canada launches Let’s Make Time campaign for Diabetes Awareness Month
November 01, 2023 05:30 ET | Diabetes Canada
Toronto, ON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- November is Diabetes Awareness Month and this year, Diabetes Canada is calling on Canadians to show support for people affected by diabetes through the...
NexImmune Logo.jpg
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
October 24, 2023 08:00 ET | NexImmune, Inc.
A JDRF funded grant is being used to explore the combination of NexImmune’s antigen specific nanoparticles and an anti-CD3 mAb for prevention and treatment of type 1 diabetes GAITHERSBURG, Md.,...